AmbioPharm has multiple manufacturing suites to produce peptide APIs at gram to kilogram scale by solid phase synthesis, solution phase synthesis, or hybrid solid/solution phase synthesis.

AmbioPharm provides process development, non-GMP/GLP grade peptides for pre-clinical applications.

AmbioPharm specializes in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients at very small to very large scales.

Our team at AmbioPharm has manufactured APIs for peptide vaccines in all sorts of configurations for many groups over many years.

AmbioPharm provides Analytical  Development & Validation Services.